Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * SITEMAP: |
Title | POLIVY® (polatuzumab vedotin-piiq) Now Approved for 1L DLBCL, NOS or HGBL and IPI score of 2 or |
Description | In first-line DLBCL, NOS or HGBL and IPI ≥ Learn about POLIVY® (polatuzumab vedotin-piiq) in combination with a rituximab product, cyclophosphamide, doxorubicin, and prednisone (R-CHP) for the treatment of adult patients who have previously untreated diffuse large B-cell lymphoma (DLBCL), |
Keywords | N/A |
WebSite | polivy-hcp.com |
Host IP | 104.18.1.85 |
Location | Singapore |
Site | Rank |
US$1,365
Last updated: 2023-05-19 22:02:28
polivy-hcp.com has Semrush global rank of 0. polivy-hcp.com has an estimated worth of US$ 1,365, based on its estimated Ads revenue. polivy-hcp.com receives approximately 157 unique visitors each day. Its web server is located in Singapore, with IP address 104.18.1.85. According to SiteAdvisor, polivy-hcp.com is safe to visit. |
Purchase/Sale Value | US$1,365 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$37 |
Yearly Ads Revenue | US$453 |
Daily Unique Visitors | 10 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
polivy-hcp.com. | A | 298 | IP: 104.18.1.85 |
polivy-hcp.com. | A | 298 | IP: 104.18.0.85 |
polivy-hcp.com. | AAAA | 298 | IPV6: 2606:4700::6812:55 |
polivy-hcp.com. | AAAA | 298 | IPV6: 2606:4700::6812:155 |
polivy-hcp.com. | NS | 86400 | NS Record: alan.ns.cloudflare.com. |
polivy-hcp.com. | NS | 86400 | NS Record: lara.ns.cloudflare.com. |
polivy-hcp.com. | TXT | 300 | TXT Record: j6xl5wvpxnm2wlrvwwwk84yjblcbd5xg |
polivy-hcp.com. | TXT | 300 | TXT Record: 4sw8kxgrc15fmy3z3jkdf7s6jnsm4bph |
For Patients and Caregivers Order Practice Materials Order Practice Materials Prescribing Information Prescribing Information Contact a Representative Contact a Representative Other Indications Other Indications Safety Safety MENU Order Practice Materials Prescribing Information Contact a Representative Other Indications Safety For Patients and Caregivers In first-line DLBCL, NOS or HGBL and IPI ≥ 2 1 In first-line DLBCL, NOS or HGBL and IPI ≥ 2 1 POLIVY ® + R-CHP: Superior Progression-Free Survival (PFS) vs R-CHOP 1 in the ITT population (HR [95% CI]: 0.73 [0.57, 0.95], p=0.0177) POLARIX: A double-blind, placebo-controlled, randomized, multicenter, phase III study that evaluated the efficacy and safety of POLIVY + R-CHP (n=440) vs R-CHOP (n=439). Eligible patients had DLBCL, NOS or HGBL, or other large B-cell lymphoma (including EBV+ DLBCL, NOS and T-cell/histiocyte rich LBCL), and IPI ≥ 2. Primary endpoint was investigator assessed PFS. 1 POLIVY ® + R-CHP: Superior Progression-Free |
HTTP/1.1 301 Moved Permanently Date: Sat, 03 Dec 2022 11:23:32 GMT Connection: keep-alive Cache-Control: max-age=3600 Expires: Sat, 03 Dec 2022 12:23:32 GMT Location: https://polivy-hcp.com/ Set-Cookie: __cf_bm=YzN1MTg3j1ui58tjivJ66pkZFVC3gaV2PqDTuFPh5oE-1670066612-0-Abaa2JNjOR+BkoLHEzMp8MACb5m7EArcxgbkKdodW5PLq2XA28R+6iLp/E5W/tXvZ0yb/tHq/Usk3qzpu94fKhw=; path=/; expires=Sat, 03-Dec-22 11:53:32 GMT; domain=.polivy-hcp.com; HttpOnly; SameSite=None Set-Cookie: __cfruid=b9d70b17420ec2e542eb94457c6bb4872fcc3019-1670066612; path=/; domain=.polivy-hcp.com; HttpOnly Server: cloudflare CF-RAY: 773bee486f929152-FRA HTTP/2 301 date: Sat, 03 Dec 2022 11:23:33 GMT content-type: text/html; charset=iso-8859-1 location: https://www.polivy-hcp.com/ cf-cache-status: DYNAMIC set-cookie: __cf_bm=0Scnew7dFoMxWGPzXs3oLaK8RwTHYBTGHx3OZQ7foaE-1670066613-0-AQ7ylBksP5Dikieyqdt/4at5VcOZ4ZGcREfj1IRZCD6tKxchMc0pIP1Q8vkuQUE9xzQCMiW+tvyEney4qe1swtw=; path=/; expires=Sat, 03-Dec-22 11:53:33 GMT; domain=.polivy-hcp.com; HttpOnly; Secure; SameSite=None set-cookie: __cfruid=1ca29b16e76cdac9f82f9662342faf6a19c8b32f-1670066613; path=/; domain=.polivy-hcp.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 773bee494e19bb38-FRA HTTP/2 200 date: Sat, 03 Dec 2022 11:23:34 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding cf-cache-status: DYNAMIC set-cookie: __cf_bm=ue.rSl2vk.fHf6phmUPY48sKQBqw7D_bKxEXdg2MHFw-1670066614-0-AfgiYyA2GNwWAGg0Lvf156dfG17Je+q02TiAaDy4xGUZmmxsR9fsikqdJlj5DKCQggZQvmF/boF6oV/yEJOrqNU=; path=/; expires=Sat, 03-Dec-22 11:53:34 GMT; domain=.polivy-hcp.com; HttpOnly; Secure; SameSite=None set-cookie: __cfruid=8f649587e68cb521929834fffcba77dc9ac93a60-1670066614; path=/; domain=.polivy-hcp.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 773bee4f9ef89072-FRA |
Domain Name: POLIVY-HCP.COM Registry Domain ID: 2341836812_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2021-08-11T15:00:08Z Creation Date: 2018-12-10T08:40:03Z Registry Expiry Date: 2022-12-10T08:40:03Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: abuse@safenames.net Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: ALAN.NS.CLOUDFLARE.COM Name Server: LARA.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2022-12-03T11:06:44Z <<< |